US$ 25.52
compounded semaglutide fda enforcement 2025 news Report: must enforce rules on GLP-1s Compounded' weight-loss drugs are a
Description
The consistent signal is that both move a large majority of patients past clinically meaningful weight-loss thresholds

There was some evidence of asymmetry for MACE (Egger test, P = 0.059), suggesting a potential threat of publication bias

Analysts predict the obesity drug market could reach around $100 billion by 2030

Brand-name medications and compounded formulations are not interchangeable when it comes to how long they last and how they should be stored

Talk to your doctor about side effects first, so you know what to expect when you start a GLP-1 drug